Upcoming Policies effective December 1, 2025
Summary
Blue Cross MN has updated three medical policies effective December 1, 2025: transcatheter tricuspid valve procedures are now considered experimental/investigative, revised general medical necessity criteria for technologies without specific policies, and updated coverage criteria for hematopoietic stem cell transplantation in acute lymphoblastic leukemia patients.
Get alerts when payers change rules like this one
We check Blue Cross and Blue Shield of Minnesota and other payers every day and email you when a change matches your specialty and state.